| Beta-blockers to prevent death or serious events after heart surgery |
| Beta-blockers to prevent death or serious events after surgery not involving the heart |
| Beta-blockers versus placebo or no intervention for patients with suspected or diagnosed myocardial infarction |
| Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal varices in children |
| Beta2-adrenoceptor agonists for primary dysmenorrhoea |
| Beta2-agonist drugs for treating cough or a clinical diagnosis of acute bronchitis |
| Betahistine for Ménière's disease or syndrome |
| Betahistine for Ménière's disease or syndrome |
| Betahistine for symptoms of vertigo |
| Betahistine for tinnitus |
| Betamimetics for inhibiting preterm labour |
| Betamimetics for suspected impaired fetal growth |
| Better survival and reduced distant recurrence rate with combined chemotherapy and radiotherapy for cervical cancer |
| Beyond the Room Edinburgh Colloquium 2018 Podcasts |
| Bezafibrate for primary biliary cirrhosis |
| Biannual praziquantel treatment for schistosomiasis |
| Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions |
| Bibliotherapy for sexual dysfunction |
| Bicarbonate for acute acidosis |
| Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration |
| Bicycle helmet legislation for the uptake of helmet use and prevention of head injuries |
| Bifeprunox compared with placebo for schizophrenia |
| Big data and health |
| Bilateral (two) versus unilateral (one) hearing aid(s) for bilateral hearing impairment in adults |
| Bilateral versus single internal mammary artery bypass grafts for coronary arterial atherosclerosis |
| Bile acid derivatives for people with primary biliary cholangitis |
| Bile acid derivatives for people with primary sclerosing cholangitis |
| Bile acid sequestrants for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia |
| Bile acids for biliary colic |
| Bile acids for cholelithiasis |
| Bile acids for liver-transplanted patients |
| Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis |
| Bile acids for primary sclerosing cholangitis |
| Bile acids may improve liver biochemistry of patients with hepatitis B or C, but there is insufficient evidence about long-term beneficial effects |
| Biliary anastomosis using T-tube versus no T-tube for liver transplantation in adults |
| Biliary drainage before major operations in patients with obstruction of the bile duct |
| Bioabsorbable versus metal screw for graft fixation in the surgical treatment of anterior cruciate ligament injury |
| Biochemical tests of placental function for assessment in pregnancy |
| Biocompatible dialysis fluids for peritoneal dialysis |
| Biodegradable anastomotic ring for gastrointestinal anastomosis |
| Biofeedback (use of equipment to retrain the muscles around the anus and coordinated pushing) for the treatment of chronic constipation in adults |
| Biofeedback for neck pain |
| Biofeedback for pain during labour |
| Biofeedback for the treatment of irritable bowel syndrome |
| Bioidentical hormones for vasomotor menopausal symptoms (hot flushes or night sweats) |
| Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis |
| Biological interventions for induction of mucosal healing in Crohn’s disease |
| Biological interventions for maintenance of mucosal healing in Crohn’s disease |
| Biological interventions for the management of fatigue in rheumatoid arthritis |
| Biologics for chronic severe asthma: a network meta-analysis |
| Biologics for people with chronic rhinosinusitis |
| Biologics for rheumatoid arthritis (RA) in people not previously treated with methotrexate (MTX) |
| Biologics for rheumatoid arthritis: an overview of Cochrane reviews |
| Biologics or tofacitinib alone for people with rheumatoid arthritis who had not improved with traditional disease-modifying anti-rheumatic drugs |
| Biologics or tofacitinib for rheumatoid arthritis |
| Biologics or tofacitinib for rheumatoid arthritis not improved by treatment with methotrexate or other disease-modifying anti-rheumatic drugs |
| Biomarkers for assessing disease activity in inflammatory bowel disease |
| Biomarkers for diagnosis of acute appendicitis in adults |
| Biomarkers to guide antibiotic therapy for COPD exacerbations |
| Biophysical profile for fetal assessment in high risk pregnancies |
| Biopsy versus resection for high-grade glioma |
| Bioresorbable fixation devices for musculoskeletal injuries in adults |
| Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction |
| Birth and death notification via mobile devices: a mixed methods review |
| Birth control pills with 20 µg estrogen versus more than 20 µg estrogen |
| Birth control pills with drospirenone for treating premenstrual syndrome |
| Birth control pills with three phases versus one phase |
| Birth control pills with three phases versus one phase |
| Birth control pills with two phases versus one phase |
| Birth control pills with two phases versus three phases |
| Birth room transition support for preterm infants: a Cochrane overview |
| Birth room transition support for term and near-term infants: a Cochrane overview |
| Bispectral index (BIS) for improving intraoperative awareness and early postoperative recovery in adults |
| Bisphosphonate therapy for children and adolescents with secondary osteoporosis. |
| Bisphosphonate therapy for osteogenesis imperfecta |
| Bisphosphonate treatment to improve bone health in children with cerebral palsy |
| Bisphosphonates and denosumab for breast cancer |
| Bisphosphonates for advanced prostate cancer |
| Bisphosphonates for osteoarthritis |
| Bisphosphonates for osteoporosis in people with cystic fibrosis |
| Bisphosphonates for osteoporosis in primary biliary cirrhosis |
| Bisphosphonates for Paget's disease of bone in adults |
| Bisphosphonates for postmenopausal osteoporosis: a network meta-analysis |
| Bisphosphonates for preventing and treating osteoporosis in men |
| Bisphosphonates for prevention of bone loss in women with early breast cancer |
| Bisphosphonates for the relief of pain secondary to bone metastases |
| Bisphosphonates for treating osteoporosis caused by the use of steroids |
| Bisphosphonates in early prostate cancer |
| Bisphosphonates in multiple myeloma |
| Black cohosh (Cimicifuga spp.) for menopausal symptoms |
| Bladder training for treating overactive bladder in adults |
| Bladder training for urinary incontinence in adults |
| Blind stretching or telescopic cutting versus open surgery for urethral narrowing in men |
| Blinded versus unblinded assessments of risk of bias in studies included in a systematic review |
| Blog - Retention to clinical trials: how can we keep participants involved? |
| Blonanserin versus risperidone for schizophrenia |
| Blood and urine tests for the diagnosis of acute pancreatitis (sudden inflammation of pancreas) |
| Blood biomarkers for the non-invasive diagnosis of endometriosis |
| Blood clotting analysers (TEG or ROTEM) versus any comparison to guide the use of blood products in adults or children with bleeding |
| Blood glucose target levels for critically ill adult patients |
| Blood pressure control for diabetic retinopathy |
| Blood pressure drugs for preventing stroke and cardiovascular diseases in patients with a stroke or transient ischaemic attack (TIA) |
| Blood pressure lowering effect of diuretics as second line therapy for primary hypertension in crossover trials |
| Blood pressure lowering effect of hydrochlorothiazide compared to other diuretics for hypertension |
| Blood pressure lowering efficacy of aliskiren |
| Blood pressure lowering efficacy of calcium channel blockers for primary hypertension |
| Blood pressure lowering efficacy of calcium-channel blockers as second-line therapy for primary hypertension |
| Blood pressure lowering efficacy of clonidine for primary hypertension |
| Blood pressure lowering efficacy of drugs inhibiting the renin-angiotensin system as second-line therapy for primary hypertension |
| Blood pressure lowering medication for adults with early stages of chronic kidney disease (without diabetes) |
| Blood pressure management in reperfused ischemic stroke |
| Blood pressure targets for older adults with high blood pressure |
| Blood pressure targets for people undergoing heart surgery |
| Blood pressure targets in people with cardiovascular disease |
| Blood pressure targets in people with cardiovascular disease |
| Blood pressure targets in people with diabetes |
| Blood substitutes for avoiding allogeneic blood transfusion |
| Blood tests for the diagnosis of pancreatic necrosis (pancreatic destruction due to inflammation of pancreas) |
| Blood tests in late pregnancy to identify small babies and those at risk of stillbirth |
| Blood thinners for pulmonary hypertension |
| Blood thinners for the initial treatment of blood clots in people with cancer |
| Blood thinners for the long-term treatment of blood clots in people with cancer |
| Blood thinners for the prevention of blood clots in people with cancer undergoing surgery |
| Blood thinners in people with multiple myeloma |
| Blood thinners to prevent blood clots in people with cancer and central venous catheters |
| Blood transfusion for anaemia in patients with advanced cancer |
| Blood transfusion for treating malarial anaemia |
| Blood transfusion policies for sickle cell disease in pregnancy |
| Blood transfusions for people with sickle cell disease before they undergo surgery |
| Blood transfusions for treating acute chest syndrome in people with sickle cell disease |
| Blood transfusions in patients with heart problems requiring surgery on their heart |
| Blood-clot promoting drugs for acute traumatic injury |
| Blue light-enhanced versus white light resection in the treatment of non-muscle invasive bladder cancer |
| Blue-light filtering spectacle lenses for visual performance, macular (back part of the eye) protection, and improving sleep quality |
| Blue-light filtering spectacles probably make no difference to eye strain, eye health or sleep quality |
| BMJ partners with Cochrane Clinical Answers to boost knowledge at the point of care |
| Body position and apnoea in the preterm infant |
| Body position and intake of fluids for preventing headache after a lumbar puncture |
| Body warming of people undergoing surgery to avoid complications and increase comfort after surgery |
| Bone grafts and bone substitutes for treating distal radial fractures in adults |
| Bone marrow cells in non-ischaemic dilated cardiomyopathy |
| Bone-modifying agents for men with prostate cancer and bone metastases |
| Boosted protease inhibitor (PI) monotherapy for treating HIV/AIDS |
| Booster dose for preventing hepatitis B infection |
| Boswellia for osteoarthritis |
| Both hormone replacement therapy and danazol stop the loss of bone density that occurs when women take gonadotrophin-releasing hormone analogues for endometriosis |
| Botulinum A toxin for focal hand dystonia |
| Botulinum toxin A injections to treat the spastic hip in cerebral palsy |
| Botulinum toxin for adult spasticity after stroke or non-progressive brain lesion |
| Botulinum toxin for drooling in Parkinson’s disease |
| Botulinum toxin for motor and phonic tics |
| Botulinum toxin for people with involuntary posturing of the head |
| Botulinum toxin for shoulder pain |
| Botulinum toxin for subacute and chronic neck pain |
| Botulinum toxin for swallowing disorders |
| Botulinum toxin for the treatment of chronic idiopathic constipation |
| Botulinum toxin for the treatment of strabismus |
| Botulinum toxin injectable drug for myofascial pain syndrome (a painful condition that could affect any muscle in the body) in adults |
| Botulinum toxin injection for tennis elbow |
| Botulinum toxin injections as a treatment for low-back pain and sciatica |
| Botulinum toxin injections for preventing migraine in adults |
| Botulinum toxin injections for the treatment of spasmodic dysphonia |
| Botulinum toxin injections for unilateral involuntary contractions of facial muscles |
| Botulinum toxin injections into the bladder for overactive bladder syndrome in adults |
| Botulinum toxin type A for masseter hypertrophy |
| Botulinum toxin type A for people with involuntary eyelid closure, or blepharospasm |
| Botulinum toxin type A formulations in focal dystonias |
| Botulinum toxin type A injections for the treatment of lower limb spasticity in cerebral palsy |
| Botulinum toxins for sleep bruxism |
| Bowel Preparation and Prokinetic Agents for Small Bowel Capsule Endoscopy |
| Bowel preparation for colonoscopy |
| Bowel Preparation for Paediatric Colonoscopy |
| Braces and orthoses for osteoarthritis of the knee |
| Braces for idiopathic scoliosis in adolescents |
| Bradykinin beta-2 receptor antagonists for traumatic brain injury |
| Brain imaging for diagnosing schizophrenia in people with first episode psychosis |
| Brain scans for people with cerebral gliomas |
| Brain-computer interface training for motor recovery after stroke |
| Branched-chain amino acid supplementation for improving nutrition in term and preterm neonates |
| Branched-chain amino acids improve symptoms of hepatic encephalopathy |
| Brazil launches first-ever Cochrane Network |
| Breaking language barriers: Cochrane adds Bahasa Indonesia to translation efforts |
| Breast Cancer Awareness Month |
| Breast cancer in female survivors of childhood, adolescent or young adult cancer after radiotherapy involving the chest for their primary malignancy |
| Breast examination during pregnancy for promoting breastfeeding |
| Breast milk expression during pregnancy by women with diabetes for improving infant outcomes |
| Breast stimulation for cervical ripening and induction of labour |
| Breast surgery for metastatic breast cancer |
| Breast-feeding is better, but using hydrolysed milk formula (instead of formulas based on cow's milk or soy) can help reduce the risk of some high-risk babies developing asthma |
| Breastfeeding education and support for women with multiple pregnancies |
| Breastfeeding for oral health in preschool children |
| Breastfeeding in infants diagnosed with phenylketonuria |
| Breastfeeding or breast milk for procedural pain in newborn babies |
| Breastfeeding the newborn or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour |
| Breathing exercises for asthma |
| Breathing exercises for children with asthma |
| Breathing exercises for chronic obstructive pulmonary disease |
| Breathing exercises for dysfunctional breathing/hyperventilation syndrome |
| Breathing muscle training for people with bronchiectasis |
| Breathing support via a mask during exercise training for people with chronic obstructive pulmonary disease |
| Breathing training before surgery for reducing lung complications after surgery in adults undergoing heart and major abdominal surgery |
| Brexanolone and related neurosteroid GABA(A) positive allosteric modulators for postnatal depression |
| Brexpiprazole versus placebo for people with schizophrenia |
| Brief alcohol questionnaires for identifying hazardous, harmful and dependent alcohol use in primary care |
| Brief co-incubation of sperm and oocytes for in vitro fertilization (IVF) techniques |
| Brief family intervention for schizophrenia |
| Brief interventions for heavy alcohol users admitted to general hospital wards |
| Brief teaching methods to improve contraceptive use among young people |
| Brief versus standard cognitive behavioural therapy for schizophrenia |
| Bright light therapy for sleep problems in adults aged 60+ |
| Bringing together scientists, artists, and storytellers - Interview with Lifeology |
| Brivaracetam add-on therapy for drug-resistant epilepsy |
| Bromocriptine does not appear to increase pregnancy rates for women with unexplained subfertility |
| Bromocriptine for idiopathic oligo/asthenospermia |
| Bromocriptine for levodopa-induced motor complications in Parkinson's disease |
| Bromocriptine for type 2 diabetes mellitus |
| Bromocriptine versus levodopa in early Parkinson's disease |
| Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease |
| Bronchial thermoplasty for people with asthma |
| Bronchodilators delivered by nebuliser versus inhalers for lung attacks of chronic obstructive pulmonary disease |
| Bronchodilators for bronchiolitis for infants with first-time wheezing |
| Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis |
| Bronchoscopic lung volume reduction procedures for moderate to severe chronic obstructive pulmonary disease |
| Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia |
| Buccal or sublingual misoprostol for cervical ripening and induction of labour |
| Budesonide at different doses for asthma |
| Budesonide for maintenance of remission in Crohn's disease |
| Budesonide for treatment of people with active Crohn's disease. |
| Budesonide versus placebo for asthma |
| Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children |
| Buffered versus non-buffered fluids given to adults during surgery |
| Buflomedil for acute ischaemic stroke |
| Buflomedil for intermittent claudication |
| Building a healthier future - Scientific strategy 2025 to 2030 |
| Building an effective sustainable organization: Goal 4 of Strategy to 2020 |
| Building stronger evidence ecosystems together: Cochrane, JBI, and Campbell's call to action |
| Built environment interventions for increasing physical activity in adults and children |
| Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome |
| Buprenorphine for managing opioid withdrawal |
| Buprenorphine for neuropathic pain in adults |
| Buprenorphine for treating people with cancer pain |
| Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence |
| Bupropion for attention deficit hyperactivity disorder (ADHD) in adults |
| Bupropion versus other antidepressive agents for depression |
| Buteyko breathing for asthma |
| Bypass for primary percutaneous intervention or thrombolysis at the nearest hospital for patients suffering ST-elevation myocardial infarction |
| Bypass surgery for chronic lower limb ischaemia |
| C-reactive protein for diagnosing infection in newborn infants |
| C-reactive protein, procalcitonin, and erythrocyte sedimentation rate for the diagnosis of lower urinary tract infection in older people |
| Cabergoline for levodopa-induced complications in Parkinson's disease |
